Proteomics

Dataset Information

0

Evaluation of Two Simultaneous Metabolomic and Proteomic Extraction Protocols Assessed by Ultra-High-Performance Liq-uid Chromatography Tandem Mass Spectrometry


ABSTRACT: Untargeted multi-omics analysis of plasma is an emerging tool for the identification of novel biomarkers for evaluating disease prognosis and for a better understanding of molecular mechanisms underlying human disease. The successful application of metabolomic and pro-teomic approaches relies on reproducibly quantifying a wide range of metabolites and proteins. Herein, we report the results of untargeted metabolomic and proteomic analyses from blood plasma samples following analyte extraction by two frequently used solvent systems: chloro-form/methanol and methanol-only. Whole blood samples were collected from participants (n=6) at University Hospital Sharjah (UHS) hospital, then plasma was separated and extracted by two methods i. methanol precipitation and, ii. 4:3 methanol:chloroform extraction. The coverage and reproducibility of the two methods were assessed by ultra-high-performance liquid chromatography-electrospray ionization quadrupole time-of-flight mass spectrometry (UHPLC-ESI-QTOF-MS). The study revealed that metabolite extraction by methanol-only showed greater reproducibility for both metabolomic and proteomic quantifications than did methanol/chloroform, while yielding similar peptide coverage. However, coverage of extracted metabolites was higher with the methanol/chloroform precipitation.

INSTRUMENT(S): timsTOF

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Plasma

SUBMITTER: Core Facility  

LAB HEAD: Mohammad H Semreen

PROVIDER: PXD038750 | Pride | 2023-01-17

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
A1-7186.d.zip Other
A2-7187.d.zip Other
A3-7188.d.zip Other
B1-7190.d.zip Other
B2-7191.d.zip Other
Items per page:
1 - 5 of 7

Similar Datasets

2024-08-10 | PXD050411 | Pride
2022-12-06 | ST002391 | MetabolomicsWorkbench
2015-05-26 | PXD001592 | Pride
2024-01-30 | MSV000093951 | MassIVE
2021-04-27 | PXD024423 | Pride
2016-01-26 | PXD002529 | Pride
2023-03-13 | PXD040716 | Pride
2024-05-22 | PXD048647 | Pride
2018-02-20 | MSV000082080 | MassIVE
2018-05-15 | MSV000082362 | MassIVE